Trial site
Ulyanovsk Regional Clinical Hospital
Ulyanovsk, Ulyanovsk Oblast 432017, RussiaNot linked to an institution yet
- 12running trials
- 1closed trial
The trials here
What the 13 trials at this site are about, from their registry records.
- Phase
- Phase 310 trials
- Phase 2/31 trial
- Status
- Active, not recruiting9 trials
- Recruiting2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Hoffmann-La Roche5 trials
- Janssen Research & Development, LLC2 trials
- Biocad1 trial
- Immunic AG1 trial
- ITMO University1 trial
- and 3 more
Running trials
Recruiting
Telegram Messenger Support for Smoking Cessation After Heart Attack
NCT07230249· ITMO University· Source
Contact: Mikhail A. Kuznetsov, MD
Recruiting
Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset
NCT07324837· Phase 3· Supergene, LLC· Source
Contact: Irina V. Greshnova, PhD
Recruiting
An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment
NCT06675955· Phase 3· Hoffmann-La Roche· Source
Active, not recruiting
Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE)
NCT05730699· Phase 3· Biocad· Source
Active, not recruiting
A Study of Real Life Treatment for Multiple Myeloma (MM)
NCT04985643· Takeda· Source
Active, not recruiting
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
NCT05201638· Phase 3· Immunic AG· Source
Active, not recruiting
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
NCT04882098· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
NCT04586010· Phase 3· Hoffmann-La Roche· Source
Active, not recruiting
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
NCT04548999· Phase 3· Hoffmann-La Roche· Source
Active, not recruiting
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
NCT04544436· Phase 3· Hoffmann-La Roche· Source
Active, not recruiting
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
NCT04035005· Phase 3· Hoffmann-La Roche· Source
Active, not recruiting
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
NCT03466411· Phase 2/3· Janssen Research & Development, LLC· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error